Aprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway
| dc.contributor.author | Alfatli, Layla Ameen Rasheed | |
| dc.contributor.author | Tweij, Thu-Alfeqar R. | |
| dc.date.accessioned | 2026-02-12T20:29:17Z | |
| dc.date.available | 2026-02-12T20:29:17Z | |
| dc.date.issued | 2025-12 | |
| dc.description | Ethical approval for the experiments in this study was obtained from the Ethics Committee of the Faculty of Pharmacy, University of Kufa, Najaf, Iraq (Approval No. 3177/2025-2-4). | |
| dc.description.abstract | Introduction and aim. Renal ischemia-reperfusion (I/R) injury is a primary cause of acute kidney injury (AKI). The NF-κB/NLRP3/caspase-1 signaling system is crucial for I/R-induced kidney damage, which leads to inflammation, pyroptosis, and tissue damage. Aprocitentan has anti-inflammatory and vasoprotective properties, suggesting its potential nephroprotective advantages. The aim of this investigation was to evaluate the protective advantages of aprocitentan against renal I/R injury in rat models. This was achieved by evaluating the impact of aprocitentan on inflammation, pyroptosis, and kidney function by altering the NF-κB/NLRP3/Caspase-1 pathway. Material and methods. Using twenty-four adult male Sprague-Dawley rats, four separate groups were formed: sham group, I/R control group, dimethyl sulfoxide group (DMSO) and aprocitentan group (10 mg/kg). Renal ischemia/reperfusion was induced by a period of forty minutes of bilateral ischemia, which was followed by two hours of reperfusion. To evaluate the renoprotective effect of aprocitentan urea, creatinine, neutrophil gelatinase-associated lipocalin (NGAL), phosphorylated nuclear factor kappa B p65 (NF-κB p65), NOD-like receptor protein 3 (NLRP3), and cysteine-aspartic protease-1 (caspase-1), were measured, along with histopathological examination. Results. Compared to the sham group, the I/R control group had significantly increased concentrations of urea, creatinine, NGAL, NF-κB p65, NLRP3, as well as caspase-1. These signs decreased in the aprocitentan group, leading to enhanced renal function, reduction of inflammation, and inhibition of pyroptosis. Histology showed a decrease in tubular inflammation and necrosis in the aprocitentan group. Conclusion. Aprocitentan decreases inflammation and inhibits pyroptosis by suppressing the NF-κB/NLRP3/Caspase-1 pathway. These results illustrate its promising potential to prevent ischemic renal diseases, including acute kidney injury. | eng |
| dc.identifier.citation | European Journal of Clinical and Experimental Medicine T. 23, z. 4 (2025), s. 936–946 | |
| dc.identifier.doi | 10.15584/ejcem.2025.4.13 | |
| dc.identifier.issn | 2544-1361 | |
| dc.identifier.uri | https://repozytorium.ur.edu.pl/handle/item/12197 | |
| dc.language.iso | eng | |
| dc.publisher | Rzeszów University Press | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | acute kidney injury | |
| dc.subject | caspase-1 | |
| dc.subject | endothelin receptor antagonist | |
| dc.subject | ischemia-reperfusion | |
| dc.subject | pyroptosis | |
| dc.subject | NLRP3 inflammasome | |
| dc.title | Aprocitentan mitigates ischemia reperfusion induced kidney injury in rats by attenuating inflammation and pyroptosis through suppressing NF-κB/NLRP3/caspase-1 signaling pathway | |
| dc.type | article |
Pliki
Oryginalny pakiet
1 - 1 z 1
Ładowanie...
- Nazwa:
- 12.Aprocitentan+mitigates+ischemia+reperfusion+induced+kidney.pdf
- Rozmiar:
- 1.3 MB
- Format:
- Adobe Portable Document Format
Pakiet licencji
1 - 1 z 1
Ładowanie...
- Nazwa:
- license.txt
- Rozmiar:
- 1.28 KB
- Format:
- Item-specific license agreed upon to submission
- Opis: